Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
526-540 of 2993 results
Transgenomic selects distributors to supply ICEme Mutation Enrichment Kits in China and Japan
By MDBR Staff Writer
Transgenomic has selected two distributors to supply its ICEme Mutation Enrichment Kits in China and Japan.
Diagnostics > In Vitro Diagnostics > News
Anteo Diagnostics to buy DIAsource ImmunoAssays
By MDBR Staff Writer
Australia's Anteo Diagnostics has agreed to acquire Belgium-based specialty diagnostics firm DIAsource ImmunoAssays, for around €15.4m (A$23.3m).
Diagnostics > In Vitro Diagnostics > News
Luminex seeks FDA approval for NxTAG Respiratory Pathogen Panel
By MDBR Staff Writer
Luminex is seeking approval from the US Food and Drug Administration (FDA) for its NxTAG Respiratory Pathogen Panel.
Diagnostics > In Vitro Diagnostics > News
Agena Bioscience introduces front-end automation for its MassARRAY System for genetic analysis
By MDBR Staff Writer
Agena Bioscience introduced the Chip prep module to automate sample handling after PCR for the MassARRAY 96-well System.
Diagnostics > In Vitro Diagnostics > News
Roche buys Lumora’s nucleic acid purification technology
By MDBR Staff Writer
Switzerland-based Roche has entered into an asset purchase agreement with Lumora for nucleic acid purification technology, in a bid to enhance its expertise in sample preparation for sequencing.
Diagnostics > In Vitro Diagnostics > News
Burning Rock, Illumina to develop molecular diagnostics for oncology
By MDBR Staff Writer
China-based diagnostics firm Burning Rock has partnered with Illumina, to develop advanced clinical applications for molecular diagnostics in oncology.
Diagnostics > In Vitro Diagnostics > News
Veritas’ myBRCA breast and ovarian cancer genetic screening test receives CE mark approval
By MDBR Staff Writer
US-based Veritas Genetics has obtained CE mark approval for its hereditary breast and ovarian cancer genetic screening test, myBRCA.
Diagnostics > In Vitro Diagnostics > News
Harvard’s Wyss Institute launches updated sepsis therapeutic device
By MDBR Staff Writer
Harvard University’s Wyss Institute for Biologically Inspired Engineering has launched an updated version of its blood-cleansing device that treats sepsis by mimicking human spleen.
Diagnostics > In Vitro Diagnostics > News
Guardant Health and Flatiron Health to develop innovative data platform to advance precision medicine for cancer and enhance patient care
By MDBR Staff Writer
Guardant Health and Flatiron Health announced a strategic collaboration to build a proprietary, cloud-based information platform integrating liquid biopsy-based genomic testing with clinical treatment and outcomes data to support the accelerated development of targeted therapies for cancer.
Diagnostics > In Vitro Diagnostics > News
BioMark Diagnostics announces progress in assay validation for clinical sample analysis
By MDBR Staff Writer
BioMark Diagnostics, a leader in next-generation diagnostics using metabolites, is pleased to announce that the assay validation to analyze the clinical samples from the Company's first 200-patient trial is anticipated to be completed within four weeks.
Diagnostics > In Vitro Diagnostics > News
OPKO Lab signs contracts with leading preferred provider networks for laboratory testing services
OPKO Health announced that it has entered into agreements with Stratose, Three Rivers Provider Network and Fortified Provider Network for testing services from OPKO Lab, including the 4Kscore Test, the only blood test that accurately identifies an individual patient’s risk for high-grade, aggressive cancer.
Diagnostics > In Vitro Diagnostics > News
Roche to buy US-based Kapa Biosystems
By MDBR Staff Writer
Switzerland-based Roche has signed an agreement to acquire US-based Kapa Biosystems, for an undisclosed amount.
Diagnostics > In Vitro Diagnostics > News
Ashion Analytics introduces new GEM Cancer Panel
By MDBR Staff Writer
Ashion Analytics has introduced new Genomic Enabled Medicine (GEM) Cancer Panel, which will help doctors to treat patients with cancer.
Diagnostics > In Vitro Diagnostics > News
Ortho Clinical Diagnostics obtains FDA 510(k) approval for Ortho Vision analyzer
By MDBR Staff Writer
Ortho Clinical Diagnostics has received 510(k) approval from the US Food and Drug Administration (FDA) for its automated Ortho Vision analyzer, developed for transfusion medicine laboratories.
Diagnostics > In Vitro Diagnostics > News
True Health Diagnostics launches new personalized patient management tool
By MDBR Staff Writer
True Health Diagnostics has introduced a new personalized patient management tool, which can identify changes in metabolism and risk of chronic disease several years ahead of traditional markers.
Diagnostics > In Vitro Diagnostics > News
526-540 of 2993 results